Sangamo BioScience (SGMO +5.2%) moves up after the company publishes research using zinc finger...

|About: Sangamo Therapeutics, Inc. (SGMO)|By:, SA News Editor

Sangamo BioScience (SGMO +5.2%) moves up after the company publishes research using zinc finger DNA-binding protein technology to insert a gene that will essentially "silence" the extra copy of a gene that causes Downs Syndrome. The procedure provides a model for studing the basic biology of Down syndrom, and could enable the development of drugs that can potentially rebalance the cellular processes and pathologies that are affected by the disorder.